Network origin in Peter Martin Hotten first degree
Entity | Entity type | Industry | |
---|---|---|---|
Rowett Research Services Ltd.
Rowett Research Services Ltd. Miscellaneous Commercial ServicesCommercial Services Rowett Research Services Ltd. provided biotechnology research services. The company was founded in 1988 and was headquartered in Aberdeen, the United Kingdom.
2
| Extinct | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Peter Martin Hotten via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Pharmaceuticals: Major | Director/Board Member | |
ANGLE Technology Ltd.
ANGLE Technology Ltd. Miscellaneous Commercial ServicesCommercial Services ANGLE Technology Ltd. provides management consulting and venture capital services. | Miscellaneous Commercial Services | President | |
NeuroTargets Ltd.
NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Pharmaceuticals: Major | Founder | |
PROVEXIS PLC | Pharmaceuticals: Other | Founder | |
Momentum Bioscience Ltd.
Momentum Bioscience Ltd. Medical/Nursing ServicesHealth Services Momentum Bioscience Ltd. develops a technology for the detection of infection in blood and other normally sterile body fluids. Its solutions include EMA Sepsis, a detection method for organisms in blood; EMA Total, a detection method for organisms in NSF; EMA Bacteria for the detection of bacteria; and EMA Fungi for the detection of fungi. The company was founded by William Henry Mullen in 2008 and is headquartered in Cardiff, the United Kingdom. | Medical/Nursing Services | Chief Executive Officer |
Statistics
International
United Kingdom | 5 |
United States | 4 |
Sectoral
Health Technology | 5 |
Commercial Services | 3 |
Health Services | 2 |
Operational
Founder | 3 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
President | 2 |
Most connected contacts
Insiders | |
---|---|
William Henry Mullen | 8 |
R. B. Leslie | 1 |
- Stock Market
- Insiders
- Peter Martin Hotten
- Company connections